Results 121 to 130 of about 78,155 (256)

Oesophageal varices, portal hypertensive gastropathy and spontaneous Sub-arachnoid haemorrhage in a case of liver cirrhosis diagnosed on autopsy.

, 2021
Luv Sharma, Pardeep Yadav, Mahender Singh   +2 more
openalex   +2 more sources

Research Communication: The Cumulated Spontaneous Portosystemic Shunts (SPSS) Area Decreases After TIPS and Impacts on Prognosis

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 3, Page 419-423, February 2026.
This study shows that both the total SPSS area and the cumulative SPSS diameter decrease significantly and persistently after TIPS placement, whereas the total shunt diameter increases slightly and the total shunt area remains stable. The relative change in SPSS area serves as an independent predictor of mortality. ABSTRACT We evaluated the dynamics of
Marlene Hintersteininger, Theresa Müllner‐Bucsics, Susanna Riegler, Nina Dominik, Georg Kramer, Christian Sebesta, Paul Thöne, Ulrika Asenbaum, Lukas Reider, Maria Schoder, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Lukas Hartl, Katharina Lampichler   +14 more
wiley   +1 more source

SARS-CoV-2 Infection Is an Independent Risk Factor for Decompensation in Cirrhosis Patients

Diseases
Background: SARS-CoV-2 causes varied gastrointestinal symptoms. Cirrhosis patients face higher mortality rates from it, especially those with decompensated cirrhosis.
Mark Ayoub, Julton Tomanguillo, Carol Faris, Nadeem Anwar, Harleen Chela, Ebubekir Daglilar   +5 more
doaj   +1 more source

Balloon Occluded Retrograde Transvenous Obliteration of Bleeding Stomal Varices Using Sodium Tetradecyl Sulfate Foam: A Case Report

, 2015
Jichang Kim, Po-Song Yang, Yeonsoo Lee, Hyun Jeong Kim, Gun Park   +4 more
openalex   +1 more source

Spleen stiffness measurement based on shear-wave elastography for noninvasive assessment of esophageal varices in liver cirrhosis cases

, 2022
Walid K. Soliman, Khaled A. Eid, Ahmed Q. Mohammad   +2 more
openalex   +1 more source

PIONEER REAL Saudi Arabia: A multicentre, prospective, real‐world study of once‐daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1304-1314, February 2026.
Abstract Aim PIONEER REAL Saudi Arabia investigated real‐world clinical outcomes associated with the use of once‐daily oral semaglutide in adults with type 2 diabetes (T2D). Materials and Methods This was a 34‐ to 44‐week multicentre, prospective, open‐label study in adults with T2D, who were treatment‐naive to injectable glucose‐lowering medication ...
Hussein ElBadawi, Nader Albalkhi, Ibrahim Al Kadhim, Ahmed Elsadig, Dimitrios Baltzis, Mohamed Hassan Hatahet, Mahmoud Ismail, Said Khader, Christina Louise Rasmussen, Stine Hedegaard Scheuer, Ahmed Shalaby, Mohammed Almehthel   +11 more
wiley   +1 more source

Bleeding esophageal varices—inject or band?

, 1992
Michael L. Kochman, Grace H. Elta
openalex   +1 more source

Characteristics and Clinical Outcomes in Patients With Cirrhosis due to MASLD in Sweden

Liver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background and Aims There is limited real‐world data on the prognosis of patients with cirrhosis due to metabolic dysfunction‐associated steatotic liver disease (MASLD). We sought to describe the characteristics and assess the clinical course of MASLD‐cirrhosis.
Ying Shang, Linnea Widman, Xiao Zhang, Gail Fernandes, Matthew G. Melaragno, Samuel S. Engel, Johan Vessby, Mattias Ekstedt, Hannes Hagström   +8 more
wiley   +1 more source

Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices [PDF]

Michał Brzdęk, Dorota Zarębska‐Michaluk, Michał Kukla, Justyna Janocha‐Litwin, Dorota Dybowska, Ewa Janczewska, Beata Lorenc, Hanna Berak, Włodzimierz Mazur, Magdalena Tudrujek‐Zdunek, Jakub Klapaczyński, Anna Piekarska, Marek Sitko, Łukasz Laurans, Anna Parfieniuk‐Kowerda, Robert Flisiak   +15 more
openalex   +1 more source

Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study

Liver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background/Aims Immune checkpoint inhibitors (ICIs) have transformed advanced HCC treatment. The benefit of sequential immunotherapy after prior ICI failure remains unclear. Given the expanded use of atezolizumab plus bevacizumab (Ate/Bev) over the past 5 years, we explored the real‐world outcomes of nivolumab plus ipilimumab (Nivo/Ipi) in ...
Jung Sun Kim, Jeffrey Wong, San‐Chi Chen, David Tai, Hannah Yang, Youngun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Chansik An, Su Jin Jang, Masatoshi Kudo, Ho Yeong Lim, Chan Kim, Thomas Yau, Hong Jae Chon   +15 more
wiley   +1 more source